With a particular focus on BC, the authors developed a mouse model of metastasis, where mice were injected with MDA-MB-231 IV, BC bone-seeking cancer cells, and found that the pharmaceutical inhibition of IL-1B bond to its receptor IL-1R, leads to a reduction in metastatic tumor growth and cellular proliferation. Here, IL1B is linked to breast cancer.